InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-27.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Ling Geoffrey M.D., Director. Director active across 2 companies, notably Catalyst Biosciences, INC.. In total, 7 disclosures have been recorded. History available since 1 July 2021. The latest transaction was filed on 19 December 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
67,416 shares0Class A Common StockSEC:0001493152-25-001099:0
12,855 shares0Common StockSEC:0001209191-22-002485:0
12,855 shares0Common StockSEC:0001209191-22-002485
2,858 shares0Common StockSEC:0001209191-21-059433:0
2,858 shares0Common StockSEC:0001209191-21-059433
2,713 shares0Common StockSEC:0001209191-21-044691
2,713 shares0Common StockSEC:0001209191-21-044691:0
7 of 7 declarations
About Ling Geoffrey M.D.
Geoffrey M.D. Ling is a Board Member of Catalyst Biosciences, Inc. As a board member, he participates in the governance of the company and strategic decision-making. Catalyst Biosciences, Inc. is a biopharmaceutical company. Geoffrey leverages his experience to help guide the company's direction and ensure compliance with regulatory standards.
